Kobayashi Pharmaceutical Co Stock Fundamentals
KBYPFDelisted Stock | USD 32.49 0.00 0.00% |
Kobayashi Pharmaceutical Co fundamentals help investors to digest information that contributes to Kobayashi Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Kobayashi Pink Sheet. The fundamental analysis module provides a way to measure Kobayashi Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kobayashi Pharmaceutical pink sheet.
Kobayashi |
Kobayashi Pharmaceutical Co Company Return On Asset Analysis
Kobayashi Pharmaceutical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Kobayashi Pharmaceutical Return On Asset | 0.0633 |
Most of Kobayashi Pharmaceutical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kobayashi Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Kobayashi Pharmaceutical Co has a Return On Asset of 0.0633. This is 111.0% higher than that of the Consumer Defensive sector and 98.88% lower than that of the Household & Personal Products industry. The return on asset for all United States stocks is 145.21% lower than that of the firm.
Kobayashi Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kobayashi Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Kobayashi Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kobayashi Pharmaceutical competition to find correlations between indicators driving Kobayashi Pharmaceutical's intrinsic value. More Info.Kobayashi Pharmaceutical Co is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.65 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Kobayashi Pharmaceutical Co is roughly 1.53 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kobayashi Pharmaceutical's earnings, one of the primary drivers of an investment's value.Kobayashi Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kobayashi Pharmaceutical's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Kobayashi Pharmaceutical could also be used in its relative valuation, which is a method of valuing Kobayashi Pharmaceutical by comparing valuation metrics of similar companies.Kobayashi Pharmaceutical is currently under evaluation in return on asset category among its peers.
Kobayashi Fundamentals
Return On Equity | 0.0968 | |||
Return On Asset | 0.0633 | |||
Profit Margin | 0.12 % | |||
Operating Margin | 0.16 % | |||
Current Valuation | 3.94 B | |||
Shares Outstanding | 76.01 M | |||
Shares Owned By Insiders | 34.50 % | |||
Shares Owned By Institutions | 21.77 % | |||
Price To Earning | 34.29 X | |||
Price To Book | 2.85 X | |||
Price To Sales | 0.03 X | |||
Revenue | 155.25 B | |||
Gross Profit | 88.77 B | |||
EBITDA | 32.49 B | |||
Net Income | 19.71 B | |||
Cash And Equivalents | 116.15 B | |||
Total Debt | 596 M | |||
Debt To Equity | 0 % | |||
Current Ratio | 3.92 X | |||
Book Value Per Share | 2,653 X | |||
Cash Flow From Operations | 22.42 B | |||
Earnings Per Share | 1.94 X | |||
Number Of Employees | 3.45 K | |||
Beta | 0.27 | |||
Market Capitalization | 5.37 B | |||
Total Asset | 252.55 B | |||
Z Score | 5.4 | |||
Annual Yield | 0.01 % | |||
Net Asset | 252.55 B | |||
Last Dividend Paid | 84.0 |
About Kobayashi Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kobayashi Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kobayashi Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kobayashi Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan. Kobayashi Pharmaceutical operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 3451 people.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Kobayashi Pink Sheet
If you are still planning to invest in Kobayashi Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kobayashi Pharmaceutical's history and understand the potential risks before investing.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |